VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
MSD's Sac-TMT Achieves First Positive Phase 3 Readout with Significant PFS and OS Benefit in Advanced Endometrial Cancer
MSD's Sac-TMT Achieves First Positive Phase 3 Readout with Significant PFS and OS Benefit in Advanced Endometrial Cancer
May 18, 2026 23:22 CST Updated May 19, 10:20
Share:
